AU2002328569A1 - Medicinal compositions containing angiotensin II receptor antagonist - Google Patents
Medicinal compositions containing angiotensin II receptor antagonistInfo
- Publication number
- AU2002328569A1 AU2002328569A1 AU2002328569A AU2002328569A AU2002328569A1 AU 2002328569 A1 AU2002328569 A1 AU 2002328569A1 AU 2002328569 A AU2002328569 A AU 2002328569A AU 2002328569 A AU2002328569 A AU 2002328569A AU 2002328569 A1 AU2002328569 A1 AU 2002328569A1
- Authority
- AU
- Australia
- Prior art keywords
- compositions containing
- receptor antagonist
- medicinal compositions
- containing angiotensin
- angiotensin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002333 angiotensin II receptor antagonist Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001257435 | 2001-08-28 | ||
JP2001-257435 | 2001-08-28 | ||
PCT/JP2002/008629 WO2003020315A1 (en) | 2001-08-28 | 2002-08-27 | Medicinal compositions containing angiotensin ii receptor antagonist |
Publications (3)
Publication Number | Publication Date |
---|---|
AU2002328569A1 true AU2002328569A1 (en) | 2003-06-05 |
AU2002328569B2 AU2002328569B2 (en) | 2005-09-22 |
AU2002328569B9 AU2002328569B9 (en) | 2005-10-27 |
Family
ID=19085097
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002328569A Ceased AU2002328569B9 (en) | 2001-08-28 | 2002-08-27 | Medicinal compositions containing angiotensin II receptor antagonist |
Country Status (17)
Country | Link |
---|---|
US (1) | US20040198788A1 (en) |
EP (1) | EP1421953A4 (en) |
KR (1) | KR20040032969A (en) |
CN (1) | CN1589154A (en) |
AU (1) | AU2002328569B9 (en) |
BR (1) | BR0212254A (en) |
CA (1) | CA2459017A1 (en) |
CO (1) | CO5560583A2 (en) |
HU (1) | HUP0401696A2 (en) |
IL (1) | IL160438A0 (en) |
MX (1) | MXPA04001878A (en) |
NO (1) | NO20041291L (en) |
NZ (1) | NZ531346A (en) |
PL (1) | PL368843A1 (en) |
RU (1) | RU2004105965A (en) |
WO (1) | WO2003020315A1 (en) |
ZA (1) | ZA200401603B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3874419B2 (en) * | 2003-01-31 | 2007-01-31 | 三共株式会社 | Pharmaceuticals for the prevention and treatment of arteriosclerosis and hypertension |
WO2007086980A2 (en) * | 2005-11-10 | 2007-08-02 | Duke University | Methods of determining the risk of developing coronary artery disease |
KR101345876B1 (en) * | 2012-01-31 | 2013-12-30 | 인제대학교 산학협력단 | Composition for preserving cells, tissue or organs containing Fimasartan |
CN112979617A (en) * | 2019-12-17 | 2021-06-18 | 中国科学院苏州纳米技术与纳米仿生研究所 | Irbesartan piperazine salt and preparation method and application thereof |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES8705837A1 (en) * | 1985-01-10 | 1987-05-16 | Tanabe Seiyaku Co | Naphthalene derivatives, process for the preparation thereof and pharmaceutical composition containing same. |
US5138069A (en) * | 1986-07-11 | 1992-08-11 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking imidazoles |
EP0421441B1 (en) * | 1989-10-06 | 1995-01-25 | Fujirebio Inc. | Pantothenic acid derivatives |
DE19675036I2 (en) * | 1990-02-19 | 2004-10-21 | Novartis Ag | Acyl compounds. |
US5196444A (en) * | 1990-04-27 | 1993-03-23 | Takeda Chemical Industries, Ltd. | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
GB9025509D0 (en) * | 1990-11-23 | 1991-01-09 | Fujisawa Pharmaceutical Co | New amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same |
DE69119434T2 (en) * | 1990-11-26 | 1996-09-12 | Taisho Pharmaceutical Co Ltd | ANILIDE DERIVATIVE |
US5614519A (en) * | 1991-02-06 | 1997-03-25 | Karl Thomae Gmbh | (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists |
IS1756B (en) * | 1991-02-21 | 2000-12-28 | Sankyo Company Limited | Analogue method for the preparation of 1-biphenylmethylimidazole derivatives |
US5491172A (en) * | 1993-05-14 | 1996-02-13 | Warner-Lambert Company | N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents |
JP3720395B2 (en) * | 1994-09-20 | 2005-11-24 | 京都薬品工業株式会社 | Novel heterocyclic derivative, production method thereof and pharmaceutical use thereof |
ATE210116T1 (en) * | 1995-10-05 | 2001-12-15 | Kyoto Pharma Ind | NEW HETEROCYCLIC DERIVATIVES AND THEIR MEDICAL APPLICATIONS |
FR2741619B1 (en) * | 1995-11-28 | 1998-02-13 | Pf Medicament | NOVEL 2,3,5-TRIMETHYL-4-HYDROXY-ANILIDES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
CA2197364A1 (en) * | 1996-02-15 | 1997-08-16 | Toshikazu Suzuki | Phenol compound and process for preparing the same |
JPH11228416A (en) * | 1997-10-23 | 1999-08-24 | Takeda Chem Ind Ltd | Lipid reducing |
US6221897B1 (en) * | 1998-06-10 | 2001-04-24 | Aventis Pharma Deutschland Gmbh | Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use |
DE19916108C1 (en) * | 1999-04-09 | 2001-01-11 | Aventis Pharma Gmbh | 1,4-Benzothiazepine-1,1-dioxide derivatives substituted with sugar residues, process for their preparation and their use |
CA2445322C (en) * | 2001-04-25 | 2011-06-14 | Takeda Chemical Industries, Ltd. | Use of the abc expression promoting agent pioglitazone for the treatment of arteriosclerosis obliterans |
-
2002
- 2002-08-27 PL PL02368843A patent/PL368843A1/en not_active Application Discontinuation
- 2002-08-27 IL IL16043802A patent/IL160438A0/en unknown
- 2002-08-27 BR BR0212254-5A patent/BR0212254A/en not_active IP Right Cessation
- 2002-08-27 CN CNA028213645A patent/CN1589154A/en active Pending
- 2002-08-27 WO PCT/JP2002/008629 patent/WO2003020315A1/en not_active Application Discontinuation
- 2002-08-27 MX MXPA04001878A patent/MXPA04001878A/en unknown
- 2002-08-27 AU AU2002328569A patent/AU2002328569B9/en not_active Ceased
- 2002-08-27 RU RU2004105965/15A patent/RU2004105965A/en not_active Application Discontinuation
- 2002-08-27 EP EP02762874A patent/EP1421953A4/en not_active Withdrawn
- 2002-08-27 HU HU0401696A patent/HUP0401696A2/en unknown
- 2002-08-27 KR KR10-2004-7002806A patent/KR20040032969A/en not_active Application Discontinuation
- 2002-08-27 NZ NZ531346A patent/NZ531346A/en unknown
- 2002-08-27 CA CA002459017A patent/CA2459017A1/en not_active Abandoned
-
2004
- 2004-02-26 ZA ZA200401603A patent/ZA200401603B/en unknown
- 2004-02-26 US US10/789,340 patent/US20040198788A1/en not_active Abandoned
- 2004-03-16 CO CO04024652A patent/CO5560583A2/en unknown
- 2004-03-26 NO NO20041291A patent/NO20041291L/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002324624A1 (en) | Sequestered antagonist formulations | |
IL158079A0 (en) | Pharmaceutical compositions containing an interleukin-6 antagonist | |
AU2002313236A1 (en) | Medicinal compositions | |
HK1072200A1 (en) | Pro-micelle pharmaceutical compositions | |
IL159725A0 (en) | Pharmaceutical compositions containing benzimidazole derivatives | |
AU2002367424A1 (en) | Androgen receptor antagonists | |
GB0111597D0 (en) | Pharmaceutical compositions | |
AUPR833401A0 (en) | G protein-coupled receptor antagonists | |
EG24194A (en) | 5ht-a-partial agonist pharmaceutical compositions | |
AU2002337803A1 (en) | Sustained release pharmaceutical compositions | |
AU2001296013A1 (en) | Pgd2 receptor antagonistic pharmaceutical compositions | |
AU2002302147A1 (en) | Pharmaceutical composition | |
AUPR602501A0 (en) | Sustained release pharmaceutical composition | |
HUP0400850A3 (en) | Oral pharmaceutical compositions | |
AU2002365655A1 (en) | 5-ht7 receptor antagonists | |
IL160715A0 (en) | Pharmaceutical compositions containing an a1 adenosine receptor antagonist | |
AU2002328569A1 (en) | Medicinal compositions containing angiotensin II receptor antagonist | |
GB0104752D0 (en) | Pharmaceutical compositions | |
EP1421953A4 (en) | Medicinal compositions containing angiotensin ii receptor antagonist | |
GB2382302B (en) | Pharmaceutical compositions | |
AUPR529701A0 (en) | Pharmaceutical composition | |
AU2002346223A1 (en) | Medicinal compositions | |
AU2002338040A1 (en) | Receptor antagonist | |
AU2003241991A1 (en) | Drug composition containing calcium channel antagonist | |
GB0126732D0 (en) | Pharmaceutical compositions |